Results 41 to 50 of about 2,781,168 (197)

Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries

open access: yesHealth Research Policy and Systems, 2018
Background The use of economic evaluation in healthcare policies and decision-making, which is limited in low- and middle-income countries (LMICs), might be promoted through the improvement of the conduct and reporting of studies. Although the literature
Alia Luz   +3 more
doaj   +1 more source

Possible long COVID healthcare pathways: a scoping review

open access: yesBMC Health Services Research, 2022
Background Individuals of all ages and with all degrees of severity of the coronavirus disease (COVID) can suffer from persisting or reappearing symptoms called long COVID.
Sarah Wolf   +2 more
doaj   +1 more source

Mapping the characteristics, concepts and methodologies of matching-adjusted indirect comparison studies assessing pharmacological therapies in oncology: a scoping review protocol

open access: yesBMJ Open, 2023
Introduction Matching-adjusted indirect comparison (MAIC) studies are a subtype of indirect comparison, which uses propensity score weighting to enhance comparability.
Haliton Alves De Oliveira Junior   +8 more
doaj   +1 more source

Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach [PDF]

open access: yes, 2009
Copyright © Cambridge University Press 2009Objectives: This study assesses the impact of the English National Health Service (NHS) Health Technology Assessment (HTA) program using the "payback" framework.Methods: A survey of lead investigators of all ...
Buxton   +10 more
core   +1 more source

Maternal and child health voucher scheme in Myanmar: a review of early stage implementation

open access: yesBMC Health Services Research, 2016
Background The Maternal and Child Health Voucher Scheme (MCHVS) was introduced in Myanmar to address the high rate of maternal and infant mortalities.
Songyot Pilasant   +7 more
doaj   +1 more source

The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups

open access: yesФармакоэкономика, 2020
Diagnosis-Related Groups (DRG) for the payment for biological therapy were created at the stage of the pilot project and their coefficients of input intensity were not revised since then.
E. V. Derkach   +6 more
doaj   +1 more source

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review

open access: yesGMS German Medical Science, 2022
Objective: The goal of this review was to identify decision-analytic modeling studies in early health technology assessments (HTA) of high-risk medical devices, published over the last three years, and to provide a systematic overview of model purposes ...
Conrads-Frank, Annette   +9 more
doaj   +1 more source

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis [PDF]

open access: yes, 2013
© Queen’s Printer and Controller of HMSO 2013Severe allergic rhinitis uncontrolled by conventional medication can substantially affect quality of life. Immunotherapy involves administering increasing doses of a specific allergen, with the aim of reducing
Barton, P   +7 more
core   +1 more source

Health technology assessment of pathogen reduction technologies applied to plasma for clinical use [PDF]

open access: yes, 2016
Although existing clinical evidence shows that the transfusion of blood components is becoming increasingly safe, the risk of transmission of known and unknown pathogens, new pathogens or re-emerging pathogens still persists.
Berrino, Alexandra   +18 more
core   +1 more source

Policy models for preventative interventions in cardiometabolic diseases: a systematic review

open access: yesBMC Health Services Research
Background Cardiometabolic diseases (CMDs), including cardiovascular disease (CVD) and type 2 diabetes (T2DM), are major contributors to morbidity, mortality, and rising healthcare costs.
Septiara Putri   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy